Table 2.
EORTC QLQ-NMIBC24 Scores Prior to Treatment
| Domain | Gontero 2013 (N=118) |
Siracusano 2018 (N=103) |
Park 2018 (N=249) |
|---|---|---|---|
| Urinary symptoma | 11.1 | 14.6 | 24.9 |
| Problem about cystoscopy exama | NR | 21.4 | NR |
| Intravesical treatment problema | 12.1 | NR | 18.9 |
| Future perspective/worry about future diseasea | 48.4 | 39.3 | 40.1 |
| Abdominal bloating and flatulencea | 9.6 | 10.0 | 13.6 |
| Erection problem (male)a | NR | 24.3 | 37.4 |
| Vaginal problem (female)a | NR | 7.7 | 26.3 |
| Feeling uneasy about sexual intercoursea | NR | 21.1 | 17.6 |
| Sexual functioningb | 17.3 | 23.3 | 23.0 |
Notes: Data from these studies.9,25,33 aScores range from 0 to 100 with higher scores indicating worse symptoms or problems. bScores range from 0 to 100 with higher scores indicating better level of function.
Abbreviations: EORTC QLQ-NMIBC24, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire non-muscle invasive bladder cancer 24; NR, not reported.